4th August 2025
4th August 2025
Further to the update of 1st August 2025, the Company confirms that the commercial transaction continues to progress towards a positive conclusion. All parties remain actively engaged, with continued input from our Transaction Agent (NED).
Our transaction is with a healthcare company specialising in software and telemedicine, including advanced data capabilities for biomarker extrapolation.
The transaction will be announced during August. The value of the transaction and the process for distributing payments to shareholders, following the buyer’s announcement, remain as previously advised.
The licensing transaction remains in place, with all terms unchanged. Contact from the licensing paying agent will begin shortly after the buyer announces the commercial transaction.
We will continue to update shareholders as soon as there are material developments, and we wish to reassure all parties that our priority is to finalise both transactions and release funds to shareholders as soon as possible.
The Company remains bound by strict non-disclosure agreements relating to these arrangements.
All updates and official information will be published exclusively at www.cloudtag.com.